Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Shiao-Ya Hong"'
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Ferroptosis, an iron-dependent form of regulated cell death, plays a crucial role in modulating the therapeutic response in non-small cell lung cancer (NSCLC) patients. Studies have identified the signal transducer and activator of transcrip
Externí odkaz:
https://doaj.org/article/dfe069234b2e46d79ac3661a41031971
Autor:
Shiao-Ya Hong, Ya-Ting Lu, Shih-Yu Chen, Chiung-Fang Hsu, Yi-Chun Lu, Cheng-Yi Wang, Kun-Lun Huang
Publikováno v:
Cell Death and Disease, Vol 14, Iss 6, Pp 1-12 (2023)
Abstract Idiopathic pulmonary fibrosis is a progressive fibrotic disorder with no cure that is characterized by deterioration of lung function. Current FDA-approved drugs for IPF delay the decline in lung function, but neither reverse fibrosis nor si
Externí odkaz:
https://doaj.org/article/3bcb3908a0a5467c98079ce354a25f05
Autor:
Chun-Lung Chiu, Shiao-Ya Hong, Ying Tan, Yuh-Ru Julie Lee, Yi-Ping Shih, Clifford G. Tepper, Su Hao Lo
Publikováno v:
Genes and Diseases, Vol 10, Iss 3, Pp 643-646 (2023)
Externí odkaz:
https://doaj.org/article/7310289ff01f4a5c9fbb5f4672340fcb
Autor:
Shiao-Ya Hong, Chih-Cheng Lai, Nai-Chi Teng, Chao-Hsien Chen, Chun-Chun Hsu, Nai-Ju Chan, Cheng-Yi Wang, Ya-Hui Wang, You Shuei Lin, Likwang Chen
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionBeta-blockers are widely prescribed to manage hypertension and cardiovascular diseases and have been suggested as an attractive therapy to improve the prognosis of sepsis. Herein, we investigated the potential benefits of premorbid select
Externí odkaz:
https://doaj.org/article/580f7dd1fc1543c1bff7dbb55b96abca
Autor:
Shih‐Hsin Hsiao, Wan‐Ting Chen, Chi‐Li Chung, Yu‐Ting Chou, Sey‐En Lin, Shiao‐Ya Hong, Jer‐Hwa Chang, Tzu‐Hao Chang, Li‐Nien Chien
Publikováno v:
Cancer Medicine, Vol 11, Iss 10, Pp 2067-2078 (2022)
Abstract Background and Purpose Although cytotoxic platinum‐based adjuvant chemotherapy (pACT) has been recommended for patients with completely resected early‐stage (ES) non–small‐cell lung cancer (ES‐NSCLC), therapeutic regimens for NSCLC
Externí odkaz:
https://doaj.org/article/28d710f2b7614221858f539ac4e9e7ee
Autor:
Shih-Hsin Hsiao, Yuh-Mou Sue, Chih-Chin Kao, Hui-Wen Chang, Yen-Chung Lin, Ching-Sheng Hung, Yi-Chen Hsieh, Shiao-Ya Hong, Chi-Li Chung, Jer-Hwa Chang, Ying-Shih Su, Ming-Che Liu, Kevin Shu-Leung Lai, Ko-Ling Chien, Jude Chu-Chun Wang, Chung-Yi Cheng, Te-Chao Fang
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1161 (2023)
Background: Hemodialysis patients are at an increased risk of SARS-CoV-2 infection and are excluded from preauthorization COVID-19 vaccine trials; therefore, their immunogenicity is uncertain. Methods: To compare the antibody responses to homologous
Externí odkaz:
https://doaj.org/article/8b2eb08ccf0d47cf8f3adb3f14a378ae
Publikováno v:
Clinical and Experimental Obstetrics & Gynecology, Vol 49, Iss 10, p 234 (2022)
Background: Benign leiomyomas (LM) and malignant leiomyosarcomas (LMS) can be distinguished by increased cellularity with mitotic activity. Uterine smooth muscle tumors of uncertain malignant potential (STUMP) are a group of rare tumors in between, f
Externí odkaz:
https://doaj.org/article/b3a814e29edd4fca840513671b8a5921
Autor:
Jer-Hwa Chang, Jeng-Fong Chiou, Ching-Sheng Hung, Ming-Che Liu, Hui-Wen Chang, Shiao-Ya Hong, Cheng-Yi Wang, Yi-Ling Lin, Yi-Chen Hsieh, Chi-Li Chung, Ying-Shih Su, Shu-Tai Shen Hsiao, Doresses Liu, Jian-Jong Liang, Chun-Che Liao, Chih-Shin Chang, Kevin Shu-Leung Lai, Han-Chuan Chuang, Ko-Ling Chien, Wei-Ciao Wu, Yuan-Chii G. Lee, Sey-En Lin, Yung-Kang Shen, Chiung-Fang Hsu, Jude Chu-Chun Wang, Shih-Hsin Hsiao
Publikováno v:
Vaccines, Vol 10, Iss 2, p 312 (2022)
Background: The ChAdOx1 nCoV-19 vaccine has been widely administered against SARS-CoV-2 infection; however, data regarding its immunogenicity, reactogenicity, and potential differences in responses among Asian populations remain scarce. Methods: 270
Externí odkaz:
https://doaj.org/article/3fc9e74a83354ee9a7c8d4dbdf0558b7
Autor:
Shiao-Ya Hong, 洪小雅
98
Hepatitis delta virus (HDV) is the simplest RNA virus that employs a unique strategy for viral replication. Once the virus enters the cells, it uses cellular RNA polymerases and one viral protein, small hepatitis delta antigen (SHDAg), for vi
Hepatitis delta virus (HDV) is the simplest RNA virus that employs a unique strategy for viral replication. Once the virus enters the cells, it uses cellular RNA polymerases and one viral protein, small hepatitis delta antigen (SHDAg), for vi
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/99899853125669102018
Autor:
Fang, Shih-Hsin Hsiao, Yuh-Mou Sue, Chih-Chin Kao, Hui-Wen Chang, Yen-Chung Lin, Ching-Sheng Hung, Yi-Chen Hsieh, Shiao-Ya Hong, Chi-Li Chung, Jer-Hwa Chang, Ying-Shih Su, Ming-Che Liu, Kevin Shu-Leung Lai, Ko-Ling Chien, Jude Chu-Chun Wang, Chung-Yi Cheng, Te-Chao
Publikováno v:
Vaccines; Volume 11; Issue 7; Pages: 1161
Background: Hemodialysis patients are at an increased risk of SARS-CoV-2 infection and are excluded from preauthorization COVID-19 vaccine trials; therefore, their immunogenicity is uncertain. Methods: To compare the antibody responses to homologous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::4d2000eaf7fe8db44e87e273554827fb